Showing results (121-130 of 331) with videos related to

Sort By:
Pageof 34
Geriatrics & Gerontology International|August 28, 2015
Comprehensive Geriatric Assessment is a useful predictive tool for postoperative delirium after gastrointestinal surgery in old-old adultsYoshihiro Maekawa, Ken Sugimoto, Makoto Yamasaki, et al.
Clinical Pharmacology and Therapeutics|September 7, 2017
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 GenotypeTakuma Kagami, Mihoko Yamade, Takahiro Suzuki, et al.
Digestion|January 9, 2018
Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled TrialShu Sahara, Mitsushige Sugimoto, Hitomi Ichikawa, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2008
A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese populationKen Sugimoto, Hiroshi Akasaka, Tomohiro Katsuya, et al.
Anticancer Research|January 4, 2012
Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequenceMihoko Yamade, Mitsushige Sugimoto, Masafumi Nishino, et al.
Journal of Clinical Pharmacology|October 15, 2013
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapyTakahisa Furuta, Mitsushige Sugimoto, Mihoko Yamade, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 7, 2026
Comparison of Changes in Biomarkers With Changes in Endoscopic Scores in Patients With Ulcerative Colitis: A Single-Center, Retrospective, Observational StudyYosuke Yamada, Natsuki Ishida, Tomohiro Takebe, et al.
Medicine|April 12, 2024
Ustekinumab effectiveness in Crohn's disease with lesions in the intestinesSatoshi Tamura, Yusuke Asai, Natsuki Ishida, et al.
Plos One|January 2, 2024
Albumin change predicts failure in ulcerative colitis treated with adalimumabNatsuki Ishida, Kenichi Takahashi, Yusuke Asai, et al.
Scientific Reports|June 15, 2021
C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitisNatsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, et al.
Pageof 34